News
Manufacturers are struggling with how best to respond to the increasing volume of 340B self-reporting offers and checks from Covered Entities. In response, CiiTA is pleased to introduce the Manufacturer 340B Self-Reporting Assistance offering. CiiTA assists manufacturers by providing guidance and data analysis to support investigation into events triggering self-reporting letters and refund checks. Our…
Read MorePORTLAND, Ore. – May 9, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming 340B Manufacturer Summit in Washington, DC August 18-19, 2016. This event, hosted by CBI, breaks down and clarifies the impending regulations impacting 340B programs, provides strategies to develop comprehensive self-disclosure response and auditing processes, and best…
Read MorePORTLAND, Ore. – April 25, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming 15th Annual Medicaid and GP Congress in Orlando, Florida May 18-20, 2016. This event, hosted by CBI, is an invaluable opportunity to learn and receive updates on government pharmaceutical programs while also having the opportunity…
Read MoreAt present most manufacturers are not actively or effectively managing their exposure to 340B duplicate discounts. Current projections of the scope of the issue are severely limited by a lack of data, and many manufacturers are completely unaware of the significance of the problem. Additionally, the data required to identify duplicate claims is difficult to…
Read MorePORTLAND, Ore. – April 25, 2016 — CiiTA founder and managing partner Jason Hardaway is invited to speak at the upcoming third-annual National Leadership Summit on 340B in Washington, D.C. on May 17, 2016. This summit is the annual opportunity for stakeholders to engage in meaningful and transparent dialogue to ensure the 340B program’s future…
Read MoreFor Immediate Release PORTLAND, Ore. – March 10, 2016 — CiiTA founder and managing partner Jason Hardaway has been invited to speak at the upcoming CBI GPO Membership, 340B and Class of Trade Management conference on March 23 & 24 in Philadelphia. This conference is Bio/Pharma’s premier event on roster management, class of trade verification…
Read MoreOver the past year, we here at CiiTA have become increasingly concerned about the potential 340B/Medicaid duplicate discount risk to manufacturers. We recently looked into this for a couple of our clients and found what amounts to a perfect storm of insidious financial exposure: 1) a surge in eligible claims thanks to the ACA-directed Medicaid…
Read MoreTuesday, August 18, 2015 marked the 25th anniversary of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, the legislation that created the most comprehensive Federal program that provides services exclusively to people living with HIV. On August 18, 1990, President Bush signed the groundbreaking Ryan White CARE Act that passed Congress with overwhelmingly bipartisan…
Read More- « Previous
- 1
- 2
Develop Your 340B Strategy
CiiTA has, through extensive experience, developed a set of best practices to help guide you through the creation of your 340B strategy. Download our process document to facilitate the development of your strategy.